With 2-pronged filing, Novartis' CAR-T med Kymriah aims to jump into Europe with both feet
admin 6th November 2017 Uncategorised 0Novartis is blazing ahead with its bid to take its CAR-T therapy into new realms with a two-in-one application in Europe. It’s asking EU regulators to clear Kymriah for ALL and DLBCL, setting itself to go head-to-head with Gilead.
More: With 2-pronged filing, Novartis' CAR-T med Kymriah aims to jump into Europe with both feet
Source: fierce